Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity

ACS Chemical Biology

Volumn 9, Issue 2, 2014, Pages 510-516

  Zhu, Lei ^a,b   Ma, Ying ^b   Kiesewetter, Dale O ^b   Wang, Ye ^c   Lang, Lixin ^b   Lee, Seulki ^b   Niu, Gang ^b   Chen, Xiaoyuan ^b  

^a XIAMEN UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; DEXTRO LYSINE; LYSINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG SCREENING; ENZYME DEGRADATION; ENZYME KINETICS; EX VIVO STUDY; HALF LIFE TIME; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CLEARANCE; LIQUID CHROMATOGRAPHY; MICHAELIS CONSTANT; MOLECULAR MODEL; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE;

ANIMALS; CELL LINE, TUMOR; ENZYME ASSAYS; FEMALE; FLUORESCENT DYES; HUMANS; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 13; MICE; MICE, NUDE; MOLECULAR IMAGING; NEOPLASMS; OPTICAL IMAGING;

EID: 84896710015     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400698s     Document Type: Article

References (30)

1. Massoud, T. F. and Gambhir, S. S. (2003) Molecular imaging in living subjects: Seeing fundamental biological processes in a new light Genes Dev. 17, 545-580
2. Rudin, M. and Weissleder, R. (2003) Molecular imaging in drug discovery and development Nat. Rev. Drug Discovery 2, 123-131
3. Ntziachristos, V., Ripoll, J., Wang, L. V., and Weissleder, R. (2005) Looking and listening to light: The evolution of whole-body photonic imaging Nat. Biotechnol. 23, 313-320
4. Kobayashi, H. and Choyke, P. L. (2011) Target-cancer-cell-specific activatable fluorescence imaging probes: Rational design and in vivo applications Acc. Chem. Res. 44, 83-90
5. Turk, B. (2006) Targeting proteases: Successes, failures and future prospects Nat. Rev. Drug Discovery 5, 785-799
6. Vergnolle, N., Wallace, J. L., Bunnett, N. W., and Hollenberg, M. D. (2001) Protease-activated receptors in inflammation, neuronal signaling and pain Trends Pharmacol. Sci. 22, 146-152
7. van Kempen, L. C., de Visser, K. E., and Coussens, L. M. (2006) Inflammation, proteases and cancer Eur. J. Cancer 42, 728-734
8. Zhu, L., Zhang, F., Ma, Y., Liu, G., Kim, K., Fang, X., Lee, S., and Chen, X. (2011) In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity Mol. Pharmaceutics 8, 2331-2338
9. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashier, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., Carter, D. B., Tomasselli, A. G., Parodi, L. A., Heinrikson, R. L., and Gurney, M. E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity Nature 402, 533-537
10. Holmberg, S. D., Moorman, A. C., Williamson, J. M., Tong, T. C., Ward, D. J., Wood, K. C., Greenberg, A. E., and Janssen, R. S. (2002) Protease inhibitors and cardiovascular outcomes in patients with HIV-1 Lancet 360, 1747-1748
11. Zhu, L., Huang, X., Choi, K. Y., Ma, Y., Zhang, F., Liu, G., Lee, S., and Chen, X. (2012) Real-time monitoring of caspase cascade activation in living cells J. Controlled Release 163, 55-62
12. Choi, K. Y., Swierczewska, M., Lee, S., and Chen, X. (2012) Protease-activated drug development Theranostics 2, 156-178
13. Cheng, X. W., Shi, G. P., Kuzuya, M., Sasaki, T., Okumura, K., and Murohara, T. (2012) Role for cysteine protease cathepsins in heart disease: Focus on biology and mechanisms with clinical implication Circulation 125, 1551-1562
14. Cai, Y., Zhu, L., Zhang, F., Niu, G., Lee, S., Kimura, S., and Chen, X. (2013) Noninvasive Monitoring of Pulmonary Fibrosis by Targeting Matrix Metalloproteinases (MMPs) Mol. Pharmaceutics 10, 2237-2247
15. Contag, C. H. and Bachmann, M. H. (2002) Advances in in vivo bioluminescence imaging of gene expression Annu. Rev. Biomed. Eng. 4, 235-260
16. Luo, S., Zhang, E., Su, Y., Cheng, T., and Shi, C. (2011) A review of NIR dyes in cancer targeting and imaging Biomaterials 32, 7127-7138
17. Myochin, T., Hanaoka, K., Komatsu, T., Terai, T., and Nagano, T. (2012) Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene J. Am. Chem. Soc. 134, 13730-13737
18. Lee, S., Cha, E. J., Park, K., Lee, S. Y., Hong, J. K., Sun, I. C., Kim, S. Y., Choi, K., Kwon, I. C., Kim, K., and Ahn, C. H. (2008) A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination Angew. Chem., Int. Ed. 47, 2804-2807
19. Zhu, L., Xie, J., Swierczewska, M., Zhang, F., Quan, Q., Ma, Y., Fang, X., Kim, K., Lee, S., and Chen, X. (2011) Real-time video imaging of protease expression in vivo Theranostics 1, 18-27
20. Ntziachristos, V., Tung, C. H., Bremer, C., and Weissleder, R. (2002) Fluorescence molecular tomography resolves protease activity in vivo Nat. Med. 8, 757-760
21. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A., Jr. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat. Biotechnol. 17, 375-378
22. DeFeo-Jones, D., Garsky, V. M., Wong, B. K., Feng, D. M., Bolyar, T., Haskell, K., Kiefer, D. M., Leander, K., McAvoy, E., Lumma, P., Wai, J., Senderak, E. T., Motzel, S. L., Keenan, K., Van Zwieten, M., Lin, J. H., Freidinger, R., Huff, J., Oliff, A., and Jones, R. E. (2000) A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo Nat. Med. 6, 1248-1252
23. Albright, C. F., Graciani, N., Han, W., Yue, E., Stein, R., Lai, Z., Diamond, M., Dowling, R., Grimminger, L., Zhang, S. Y., Behrens, D., Musselman, A., Bruckner, R., Zhang, M., Jiang, X., Hu, D., Higley, A., Dimeo, S., Rafalski, M., Mandlekar, S., Car, B., Yeleswaram, S., Stern, A., Copeland, R. A., Combs, A., Seitz, S. P., Trainor, G. L., Taub, R., Huang, P., and Oliff, A. (2005) Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity Mol. Cancer Ther. 4, 751-760
24. Bremer, C., Tung, C. H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition Nat. Med. 7, 743-748
25. Seltzer, J. L., Akers, K. T., Weingarten, H., Grant, G. A., McCourt, D. W., and Eisen, A. Z. (1990) Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides J. Biol. Chem. 265, 20409-20413
26. Skidgel, R. A. (1988) Basic carboxypeptidases: Regulators of peptide hormone activity Trends Pharmacol. Sci. 9, 299-304
27. Gu, D., Ma, Y., Niu, G., Yan, Y., Lang, L., Aisa, H. A., Gao, H., Kiesewetter, D. O., and Chen, X. (2011) LC/MS evaluation of metabolism and membrane transport of bombesin peptides Amino Acids 40, 669-675
28. Ma, Y., Yang, M., Gao, H., Niu, G., Yan, Y., Lang, L., Kiesewetter, D. O., and Chen, X. (2012) Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS Amino Acids 43, 1625-1632
29. Cui, L., Nithipatikom, K., and Campbell, W. B. (2007) Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: Metabolism by bovine adrenal endothelial cells Anal. Biochem. 369, 27-33
30. Edmondson, R. D., Vondriska, T. M., Biederman, K. J., Zhang, J., Jones, R. C., Zheng, Y., Allen, D. L., Xiu, J. X., Cardwell, E. M., Pisano, M. R., and Ping, P. (2002) Protein kinase Cε signaling complexes include metabolism- and transcription/translation-related proteins: Complimentary separation techniques with LC/MS/MS Mol. Cell. Proteomics 1, 421-433